Wells Fargo
ASXC

Wells Fargo’s Asensus Surgical, Inc. ASXC Stock Holding History

Wells Fargo’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-46,516
Closed -$15.5K – 7142
2024
Q2 		$15.5K Buy
46,516
+1,949
+4% +$526 ﹤0.01% 5643
2024
Q1 		$10.3K Buy
44,567
+37
+0.1% +$11 ﹤0.01% 5756
2023
Q4 		$14.2K Buy
44,530
+28
+0.1% +$7 ﹤0.01% 5734
2023
Q3 		$12K Sell
44,502
-552
-1% -$201 ﹤0.01% 5756
2023
Q2 		$22.8K Sell
45,054
-990
-2% -$592 ﹤0.01% 5698
2023
Q1 		$30.3K Buy
46,044
+4,948
+12% +$3.35K ﹤0.01% 5444
2022
Q4 		$14.3K Buy
41,096
+1,039
+3% +$422 ﹤0.01% 5406
2022
Q3 		$18K Sell
40,057
-1,085
-3% -$566 ﹤0.01% 5462
2022
Q2 		$16K Sell
41,142
-52,556
-56% -$23.4K ﹤0.01% 5566
2022
Q1 		$59K Sell
93,698
-81,109
-46% -$62.5K ﹤0.01% 5574
2021
Q4 		$194K Buy
174,807
+9,832
+6% +$15.2K ﹤0.01% 5282
2021
Q3 		$305K Buy
164,975
+158,245
+2,351% +$355K ﹤0.01% 4919
2021
Q2 		$21K Sell
6,730
-603
-8% -$1.51K ﹤0.01% 5883
2021
Q1 		$24K Buy
7,333
+814
+12% +$2.95K ﹤0.01% 6103
2020
Q4 		$4K Buy
6,519
+332
+5% +$152 ﹤0.01% 6203
2020
Q3 		$2K Sell
6,187
-1,459
-19% -$565 ﹤0.01% 6156
2020
Q2 		$4K Sell
7,646
-40,113
-84% -$19.4K ﹤0.01% 6032
2020
Q1 		$16K Buy
47,759
+38,900
+439% +$40.6K ﹤0.01% 5658
2019
Q4 		$13K Sell
8,859
-4,892
-36% -$17K ﹤0.01% 5846
2019
Q3 		$111K Buy
13,751
+4,366
+47% +$59.4K ﹤0.01% 5271
2019
Q2 		$166K Sell
9,385
-1,855
-17% -$40.6K ﹤0.01% 5078
2019
Q1 		$347K Buy
11,240
+598
+6% +$20K ﹤0.01% 4545
2018
Q4 		$313K Sell
10,642
-2,292
-18% -$104K ﹤0.01% 4641
2018
Q3 		$975K Buy
12,934
+3,700
+40% +$250K ﹤0.01% 3992
2018
Q2 		$523K Buy
9,234
+8,196
+790% +$299K ﹤0.01% 4415
2018
Q1 		$23K Sell
1,038
-2
-0.2% -$46 ﹤0.01% 5779
2017
Q4 		$26K Buy
1,040
+883
+562% +$27.2K ﹤0.01% 5732
2017
Q3 		$3K Hold
157
– – ﹤0.01% 6119
2017
Q2 		$1K Sell
157
-6,505
-98% -$61.9K ﹤0.01% 6153
2017
Q1 		$104K Buy
6,662
+5,506
+476% +$95.4K ﹤0.01% 5181
2016
Q4 		$20K Hold
1,156
– – ﹤0.01% 5632
2016
Q3 		$25K Sell
1,156
-77
-6% -$1.41K ﹤0.01% 5541
2016
Q2 		$20K Sell
1,233
-242
-16% -$7.6K ﹤0.01% 5497
2016
Q1 		$81K Buy
1,475
+379
+35% +$16.2K ﹤0.01% 4988
2015
Q4 		$36K Buy
1,096
+1,000
+1,042% +$32.2K ﹤0.01% 5401
2015
Q3 		$2K Sell
96
-118
-55% -$4.38K ﹤0.01% 6012
2015
Q2 		$8K Buy
214
+15
+8% +$691 ﹤0.01% 5884
2015
Q1 		$8K Buy
199
+17
+9% +$641 ﹤0.01% 5714
2014
Q4 		$7K Sell
182
-384
-68% -$15.8K ﹤0.01% 5777
2014
Q3 		$33K Buy
566
+406
+254% +$21.9K ﹤0.01% 5100
2014
Q2 		$10K Buy
+160
New +$9.24K ﹤0.01% 5648

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's ASXC Position: Q3 2024 in Review

Wells Fargo sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 46,516 shares — an estimated $15.5K sold.

Wells Fargo first reported a position in ASXC in Q2 2014 and held it in 41 quarters. The position peaked at $975K in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Wells Fargo reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Wells Fargo sold 46,516 Asensus Surgical, Inc. shares in Q3 2024, an estimated $15.5K.
  • Wells Fargo first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 41 quarters.
  • Wells Fargo's Asensus Surgical, Inc. position peaked at $975K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.